- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Food Craving.
Displaying page 1 of 1.
EudraCT Number: 2021-000133-13 | Sponsor Protocol Number: 2020-01131 | Start Date*: 2022-05-05 | |||||||||||
Sponsor Name:Universitätsmedizin Göttingen | |||||||||||||
Full Title: Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder | |||||||||||||
Medical condition: Binge-Eating-Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006236-63 | Sponsor Protocol Number: EVT 302/3011 | Start Date*: 2008-01-23 | |||||||||||
Sponsor Name:Evotec Neurosciences GmbH | |||||||||||||
Full Title: A double-blind, randomized, placebo- and NRT-controlled Phase II study to assess the effects of EVT 302 alone and in combination with NRT on craving and withdrawal in healthy male smokers deprived ... | |||||||||||||
Medical condition: Smoking cessation. Assessment of the effect of EVT 302 alone or in combination with a nicotine replacement therapy (NRT) on craving and withdrawal in smokers after short-term deprivation of cigare... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003850-21 | Sponsor Protocol Number: InflaMed001 | Start Date*: 2022-08-03 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: Precision psychiatry: Anti-inflammatory medication in Immuno-metabolic depression | ||
Medical condition: Immuno metabolic Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007020-18 | Sponsor Protocol Number: 1999/07 | Start Date*: 2008-05-26 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Efficacy of baclofen in the treatment of nicotine addicted patients:randomized, double blind study of Baclofen versus placebo | |||||||||||||
Medical condition: Smoking addiction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004951-35 | Sponsor Protocol Number: DISOBBED-12 | Start Date*: 2013-01-18 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI | |||||||||||||
Full Title: Disulfiram, obesity and binge eating disorder | |||||||||||||
Medical condition: Obesity and binge eating disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004374-22 | Sponsor Protocol Number: 2020-09-HISTORI | Start Date*: 2020-12-16 | |||||||||||||||||||||
Sponsor Name:Steno Diabetes Center Odense | |||||||||||||||||||||||
Full Title: HISTORI Home-based Intervention with Semaglutide Treatment Of Neuroleptica-Related Prediabetes The effect of Semaglutide on diabetes incidence and prevention in patients with in neuroleptica-relat... | |||||||||||||||||||||||
Medical condition: Prediabetes and metabolic syndrome in SGA(second generation of antipshychotic treatment)-treated young adults with schizophrenia. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019665-28 | Sponsor Protocol Number: 10-HM11260C-201 | Start Date*: 2010-05-07 | |||||||||||
Sponsor Name:Hanmi Pharmaceutical Company Limited | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SEQUENTIAL DOSE ESCALATION STUDY OF THE SAFETY, TOLERABILITY, PHARMACODYNAMICS AND PHARMACOKINETICS OF SINGLE SUBCUTANEOUS DOSES OF HM11260C IN ADULT... | |||||||||||||
Medical condition: type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005435-75 | Sponsor Protocol Number: U1111-1261-1912 | Start Date*: 2022-07-21 | ||||||||||||||||
Sponsor Name:NOVO NORDISK. S.P.A. | ||||||||||||||||||
Full Title: Efficacy and safety of cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) once-weekly in participants with overweight or obesity | ||||||||||||||||||
Medical condition: Obesity, Overweight | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) NL (Ongoing) DK (Ongoing) FI (Ongoing) ES (Ongoing) PL (Ongoing) BG (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.